Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 4Unspecified Adult Solid Tumor, Protocol Specific 2Uterine Cervical Neoplasms 1Sarcoma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1Adenoma, Islet Cell 1

Interventions

Irinotecan 30Paclitaxel 24Gemcitabine 21Cisplatin 21Docetaxel 19Fluorouracil 15alvocidib 12Oxaliplatin 11Leucovorin 11Carboplatin 11Capecitabine 11Bortezomib 9Taxes 8Topotecan 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Vorinostat 6Immunohistochemistry 6tanespimycin 5Temozolomide 5Sorafenib 5Pemetrexed 5Early Intervention, Educational 5Chromatography, High Pressure Liquid 5Bevacizumab 57-hydroxystaurosporine 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 5ixabepilone 4bryostatin 1 4Sirolimus 4Pharmacogenomic Testing 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Unspecified Adult Solid Tumor, Protocol Specific × Endostatins × Clear all
NCT00004872 2019-12-13

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

University of Wisconsin, Madison

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004229 2013-02-11

Endostatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡